Immune-Onc Therapeutics

Data updated Nov 22, 2026Money ledger: 2 records from 2 sourcesFiled 2Full reportReport a mistake

Facts

as of Nov 22, 2026

Charting a New Course in Immunology and Oncology Drug Development. Immunotherapy, which harnesses the body's own immune system to fight against disease, has changed the way we think about treatment — and even cures.

Legal name
Immune-Onc Therapeutics, Inc.
Headquarters
Palo Alto, United States
Founded
2015
Employees
2+US Form 5500 (plan participants) · Dec 2025 · -82% in a year

These are the key facts about Immune-Onc Therapeutics on Alion as of Nov 22, 2026. Immune-Onc Therapeutics is headquartered in Palo Alto, United States. It was founded in 2015. The latest round is Venture - Series Unknown of $7M, announced in 2016.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Immune-Onc Therapeutics has $7M paid in by investors, lenders and donors.

$7MPaid in
Money innewest first
Grant
Aug 2020 · Grant
$2.1MPaid
Equity raised
Jul 2016 · Venture round
$7MPaid
Money by yearUSD, rounds and grants
2020$2.1M1 record
2016$7M1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

People

2+EmployeesUS Form 5500 (plan participants) · Dec 2025 · -82% in a year
Head countas filed and stated

Products

Products →

Immune-Onc Therapeutics has 5 clinical trials on record, 1 under way.

Clinical trials
Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors
phase 1 · completed · 38 participants · Advanced Solid Tumor
Sep 2022
Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors
phase 1 · completed · 22 participants · Solid Tumor, Adult
Apr 2022
First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients …
phase 1 · completed · 91 participants · Solid Tumor, Adult
Sep 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

Immune-Onc Therapeutics in public registers.

Legal entity active
Immune-Onc Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Patents
2
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Palo Alto United StatesHeadquarters0
Source: office addresses in postings and company registers

Milestones

2025
Team shrank to 2 was 11 · US Form 5500 (plan participants)
Aug 1, 2020
Won a grant $2.1M · CORDIS
Jul 1, 2016
2015
Founded
Each milestone is dated by its source: registers, filings, the press

Lists and programmes

Hurun Global Cheetahs
2024 · BioTech